CardioGenics (CGNH.OB) Inks “Key Milestone” Commercialization Agreement with Merck-Chimie

QualityStocks would like to highlight CardioGenics (OTCBB: CGNH), a biotechnology company dedicated to the development of products for the In-Vitro-Diagnostics market to meet unfulfilled needs. At the heart of CardioGenics Platform is a core technology for improving testing sensitivity to POC products.

In the company’s news yesterday,

CardioGenics Holdings Inc. announced an agreement with Merck-Chimie S.A.S. to commercialize CardioGenics’ proprietary paramagnetic beads to Merck-Chimie’s customers. Bead shipments will commence in mid-September of this year.

Merck-Chimie is a leading supplier of paramagnetic diagnostic beads, which are integral to every immunoassay analyzer. The bead’s role as a key analyzer component to reflect a broader market valued at roughly $1 billion.

CardioGenics’ technology improves the signaling properties of the beads, which increases the sensitivity of immunoassay analyzers up to seven times and allows for enhanced data collection for disease detection and progression.

Yahia Gawad, MD, CEO of CardioGenics, said the commercialization agreement with Merck-Chimie is a significant achievement for CardioGenics’ and that it will generate needed additional revenue flow.

“Commercialization of CardioGenics’ beads with Merck-Chimie is a key milestone for us and an important validation of our technology,” Gawad stated in the press release. “Merck’s product launch will make a strong revenue contribution and help bring us to cash flow positive.”

Per the agreement, 70 percent of net revenue from the sale of CardioGenics’ beads to Merck’s customers will be allocated to Merck, with 30 percent going to CardioGenics.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.